Proteogenomics and Differential Ion Mobility Enable the Exploration of the Mutational Landscape in Colon Cancer Cells.


Journal

Analytical chemistry
ISSN: 1520-6882
Titre abrégé: Anal Chem
Pays: United States
ID NLM: 0370536

Informations de publication

Date de publication:
06 09 2022
Historique:
pubmed: 23 8 2022
medline: 9 9 2022
entrez: 22 8 2022
Statut: ppublish

Résumé

The sensitivity and depth of proteomic analyses are limited by isobaric ions and interferences that preclude the identification of low abundance peptides. Extensive sample fractionation is often required to extend proteome coverage when sample amount is not a limitation. Ion mobility devices provide a viable alternate approach to resolve confounding ions and improve peak capacity and mass spectrometry (MS) sensitivity. Here, we report the integration of differential ion mobility with segmented ion fractionation (SIFT) to enhance the comprehensiveness of proteomic analyses. The combination of differential ion mobility and SIFT, where narrow windows of ∼

Identifiants

pubmed: 35995421
doi: 10.1021/acs.analchem.2c02056
pmc: PMC9454824
doi:

Substances chimiques

Ions 0
Proteome 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

12086-12094

Références

Mass Spectrom Rev. 2019 Nov;38(6):461-482
pubmed: 30920002
Anal Chem. 2012 Nov 6;84(21):9214-21
pubmed: 23098179
Anal Chem. 2021 Jul 20;93(28):9817-9825
pubmed: 34213903
J Proteome Res. 2020 Jan 3;19(1):554-560
pubmed: 31799850
Anal Chem. 2018 Oct 2;90(19):11503-11508
pubmed: 30179449
Anal Chim Acta. 2021 Apr 29;1156:338349
pubmed: 33781465
Anal Chem. 2018 Aug 7;90(15):9529-9537
pubmed: 29969236
J Am Soc Mass Spectrom. 2008 Sep;19(9):1286-95
pubmed: 18585054
Bioinformatics. 2015 May 15;31(10):1536-43
pubmed: 25583119
Mol Cell Proteomics. 2020 Apr;19(4):716-729
pubmed: 32051234
Mass Spectrom Rev. 2021 Oct 31;:e21741
pubmed: 34719806
Nat Methods. 2011 Oct 02;8(11):933-5
pubmed: 21963608
Anal Chem. 2018 Feb 6;90(3):2333-2340
pubmed: 29272103
Cell Syst. 2017 Jun 28;4(6):587-599.e4
pubmed: 28601559
Cancer Discov. 2017 Aug;7(8):818-831
pubmed: 28572459
J Chromatogr A. 2004 Nov 26;1058(1-2):3-19
pubmed: 15595648
J Proteome Res. 2011 Apr 1;10(4):1785-93
pubmed: 21309581
Mol Cell Proteomics. 2018 Dec;17(12):2534-2545
pubmed: 30385480
Mol Cell Proteomics. 2012 Feb;11(2):O111.014902
pubmed: 22090170
J Proteomics. 2012 Jul 16;75(13):3791-813
pubmed: 22561838
Mol Cell Proteomics. 2019 May;18(5):982-994
pubmed: 33451795
Mol Cell Proteomics. 2018 Oct;17(10):2051-2067
pubmed: 30007914
Anal Chem. 2021 Jun 29;93(25):8687-8692
pubmed: 34124897
J Proteome Res. 2021 Mar 5;20(3):1705-1715
pubmed: 33566619

Auteurs

Zhaoguan Wu (Z)

Institute for Research in Immunology and Cancer (IRIC), Université de Montréal, Montréal, Quebec 514 343-6910, Canada.
Department of Chemistry, Université de Montréal, Montréal, Quebec 514 343-6910, Canada.

Éric Bonneil (É)

Institute for Research in Immunology and Cancer (IRIC), Université de Montréal, Montréal, Quebec 514 343-6910, Canada.

Michael Belford (M)

ThermoFisher Scientific, San Jose, California 95134, United States.

Cornelia Boeser (C)

ThermoFisher Scientific, San Jose, California 95134, United States.

Maria Virginia Ruiz Cuevas (MV)

Institute for Research in Immunology and Cancer (IRIC), Université de Montréal, Montréal, Quebec 514 343-6910, Canada.
Department of Biochemistry, Université de Montréal, Montréal, Quebec 514 343-6910, Canada.

Sébastien Lemieux (S)

Institute for Research in Immunology and Cancer (IRIC), Université de Montréal, Montréal, Quebec 514 343-6910, Canada.
Department of Biochemistry, Université de Montréal, Montréal, Quebec 514 343-6910, Canada.

Jean-Jacques Dunyach (JJ)

ThermoFisher Scientific, San Jose, California 95134, United States.

Pierre Thibault (P)

Institute for Research in Immunology and Cancer (IRIC), Université de Montréal, Montréal, Quebec 514 343-6910, Canada.
Department of Chemistry, Université de Montréal, Montréal, Quebec 514 343-6910, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH